I'm glad CEO Ronald Zarrella stands behind their product. It doesn't bode well though for the quality assurance though. He is pretty much stumped on how (or even if) MoistureLoc is causing the eye fungus. That is not a good endorsement of the product when (or if) the product gets back to the market. At least Biogen Idec figured out it was TYSABRI causing the progressive multifocal leukoencephalopathy (PML)
In a conference call with analysts, the CEO was quoted by The Associated Press as saying, "As far as speculation about theories, there's a lot of them, we've run a lot of them to ground and come up with nothing." He continued, "Every additional test we've run suggests that the formulation is as safe and effective as anything on the market and in particular with regard to Fusarium."
This is a pretty scathing indictment as well:
And In a statement on the company's Web site, Zarrella declared, "Bausch & Lomb's first priority is the health and safety of consumers. ... Based on our extensive testing, analysis and further internal reviews, and communications with leading experts, the available scientific evidence does not establish any type of ReNu solution as a cause" of the infections.
Bausch & Lomb did not issue a recall or say the product should be removed from stores. But individual retailers are making their own calls on the delicate matter.
Yup we care about your safety so much that we aren't issuing a recall or even say that the product should be removed from store shelves. It was up to the retailers to make that call themselves. It feels weird that Wal-Mart cares more about my safety then a company that makes a product that goes into my eye.
No comments:
Post a Comment